Benzion Abraham Friedman serves as Executive at Cell Source, Inc., where they oversee executive responsibilities. Since joining the company, Benzion Abraham Friedman has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2021 involved transacting 19,440 shares valued at $14.6K.
Benzion Abraham Friedman currently holds 4,408,184 shares of Cell Source, Inc. (CLCS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benzion Abraham Friedman has been a net neutral trader of CLCS stock. They have purchased $0 and sold $0 worth of shares.
Benzion Abraham Friedman's most recent insider trade was on Jun 30, 2021, when they sold 19,440 shares at $0.75 per share.
Get notified when new Form 4 filings are submitted
| $0.75 |
| Discretionary |
| Jun 30, 2020 | CLCS | $14.7K | Other | 19,547 | $0.75 | Discretionary |
| Dec 31, 2019 | CLCS | $19.3K | Other | 25,675 | $0.75 | Discretionary |
| Jun 26, 2019 | CLCS | $4.0K | Other | 5,356 | $0.75 | Discretionary |
| Dec 31, 2018 | CLCS | $4.1K | Other | 5,444 | $0.75 | Discretionary |
| Aug 21, 2018 | CLCS | $5.0K | Other | 6,672 | $0.75 | Discretionary |
| Dec 4, 2017 | CLCS | $4.0K | Other | 5,400 | $0.75 | Discretionary |